BICO Group AB (publ)
SSE:BICO.ST
45.4 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | BICO Group AB (publ) |
Symbool | BICO.ST |
Munteenheid | SEK |
Prijs | 45.4 |
Beurswaarde | 3,136,000,460 |
Dividendpercentage | 0% |
52-weken bereik | 23.38 - 95.48 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Erik Gatenholm |
Website | https://bico.com |
An error occurred while fetching data.
Over BICO Group AB (publ)
BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)